TVRD
NASDAQ · Pharmaceuticals
Tvardi Therapeutics Inc
$3.29
-0.07 (-2.08%)
Open$3.45
Previous Close$3.36
Day High$3.47
Day Low$3.25
52W High$43.65
52W Low$3.38
Volume—
Avg Volume46.4K
Market Cap33.59M
P/E Ratio—
EPS$-8.36
SectorPharmaceuticals
Analyst Ratings
Buy
14 analysts
Price Target
+1,057.1% upside
Current
$3.29
$3.29
Target
$38.07
$38.07
$23.38
$38.07 avg
$43.34
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 43.18M | 63.78M | 10.81M |
| Net Income | -428,744,228 | -569,970,170 | 2.98M |
| Profit Margin | -993.0% | -943.3% | 27.6% |
| EBITDA | -447,100,157 | -627,393,130 | 3.89M |
| Free Cash Flow | — | — | 2.37M |
| Rev Growth | -32.3% | -32.3% | +19.2% |
| Debt/Equity | 0.65 | 0.65 | 0.91 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |